Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
MIRA Pharmaceuticals, Inc. (MIRA) had Operating Cash Flow per Share of $-0.36 for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
-- |
|
$-7.85M |
|
-- |
|
-- |
|
$8.02M |
|
$-8.02M |
|
$0.17M |
|
$-7.85M |
|
$-7.85M |
|
$-7.85M |
|
$-7.85M |
|
$-7.85M |
|
$-7.85M |
|
$-8.02M |
|
$-8.02M |
|
15.44M |
|
15.44M |
|
$-0.51 |
|
$-0.51 |
|
Balance Sheet Financials | |
$2.89M |
|
-- |
|
$0.04M |
|
$2.92M |
|
$0.72M |
|
-- |
|
-- |
|
$0.72M |
|
$2.20M |
|
$2.20M |
|
$2.20M |
|
16.56M |
|
Cash Flow Statement Financials | |
$-5.56M |
|
-- |
|
$3.79M |
|
$4.60M |
|
$2.83M |
|
$-1.77M |
|
$1.92M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
3.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-356.98% |
|
-356.98% |
|
-268.64% |
|
-356.98% |
|
$0.13 |
|
$-0.36 |
|
Operating Cash Flow per Share |
$-0.36 |